Literature DB >> 12899227

Incidence of neuroendocrine cells in the seminal vesicles and the prostate--an immunohistochemical study.

Hans Jörg Sommerfeld1, Alan Wayne Partin, Jürgen Pannek.   

Abstract

INTRODUCTION: Prostate and seminal vesicles (sv) are both androgen-dependent male sex accessory glands. The cancer incidence in these two organs is vastly different. Neuroendocrine (NE) cells are involved in the regulation of prostate growth, differentiation and in prostate cancer carcinogenesis. Thus, knowledge of the incidence of NE cells in sv may add to our understanding of prostate cancer etiology.
METHODS: Samples of histologically confirmed normal prostate tissue and normal sv tissue from 20 men were immunostained for chromogranin A. The incidence of stained cells was evaluated semiquantitately.
RESULTS: Neuroendocrine cells were detected in all prostate specimens, but not a single stained cell was found in any of the sv specimens.
CONCLUSIONS: The lack of NE cells and, subsequently, of biogenic amines, peptides and growth factors may be a reason for the low cancer incidence in the seminal vesicles. Alternatively, the absence of NE cells can be seen as a hint that the stem cells of the prostate and sv react differently to endogenous and exogenous stimuli, and thus in the seminal vesicles, stem cells are not transformed into NE cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12899227     DOI: 10.1023/a:1024467000088

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  22 in total

1.  Nuclear shape and nuclear matrix protein composition in prostate and seminal vesicles.

Authors:  J Pannek; Y Lakshmanan; C R Pound; P F Lemkin; J I Epstein; A W Partin
Journal:  Urology       Date:  1999-11       Impact factor: 2.649

2.  Cell turnover in human seminal vesicles and the prostate: an immunohistochemical study.

Authors:  J Pannek; R R Berges; J Sauvageot; K L Lecksell; J I Epstein; A W Partin
Journal:  Prostate Cancer Prostatic Dis       Date:  1999-07       Impact factor: 5.554

3.  Partial characterization of a thyroid-stimulating hormone-like peptide in neuroendocrine cells of the human prostate gland.

Authors:  P A Abrahamsson; H Lilja
Journal:  Prostate       Date:  1989       Impact factor: 4.104

4.  Endocrine-paracrine cells of the prostate and prostatic urethra: an ultrastructural study.

Authors:  P A di Sant'Agnese; K L De Mesy Jensen
Journal:  Hum Pathol       Date:  1984-11       Impact factor: 3.466

5.  The neuroendocrine cell population of the human prostate gland.

Authors:  R J Cohen; G Glezerson; L F Taylor; H A Grundle; J H Naudé
Journal:  J Urol       Date:  1993-08       Impact factor: 7.450

6.  The androgen receptor status of neuroendocrine cells in human benign and malignant prostatic tissue.

Authors:  S Y Nakada; P A di Sant'Agnese; R A Moynes; R A Hiipakka; S Liao; A T Cockett; P A Abrahamsson
Journal:  Cancer Res       Date:  1993-05-01       Impact factor: 12.701

7.  Neuroendocrine differentiation in prostatic carcinoma.

Authors:  P A di Sant'Agnese; K L de Mesy Jensen
Journal:  Hum Pathol       Date:  1987-08       Impact factor: 3.466

Review 8.  Neuroendocrine differentiation in carcinoma of the prostate. Diagnostic, prognostic, and therapeutic implications.

Authors:  P A di Sant'Agnese
Journal:  Cancer       Date:  1992-07-01       Impact factor: 6.860

9.  Neuroendocrine differentiation in prostatic intraepithelial neoplasia and adenocarcinoma.

Authors:  D G Bostwick; M K Dousa; B G Crawford; P C Wollan
Journal:  Am J Surg Pathol       Date:  1994-12       Impact factor: 6.394

10.  Immunohistochemical localization of parathyroid hormone-related protein in prostatic intraepithelial neoplasia.

Authors:  M Iwamura; S Gershagen; O Lapets; R Moynes; P A Abrahamsson; A T Cockett; L J Deftos; P A di Sant'Agnese
Journal:  Hum Pathol       Date:  1995-07       Impact factor: 3.466

View more
  1 in total

1.  Serotonin used as prognostic marker of urological tumors.

Authors:  Nina Jungwirth; Lothar Haeberle; Karl Michael Schrott; Bernd Wullich; Frens Steffen Krause
Journal:  World J Urol       Date:  2008-06-26       Impact factor: 4.226

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.